S.C. Ropharma S.A.

RPH

ROIAFRACNOR4

Drug Retailers

End-of-day quote Bucharest S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
0.195 ^RON	+4.84%		+2.63%	-2.50%

2023	S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2018

March 11, 2019 at 12:00 pm EDT

S.C. Ropharma S.A. Announced earnings results for the full year ended December 31, 2018. For the full year, the company announced total revenue was RON 641.355 million compared to RON 538.706 million a year ago. Operating income was RON 15.720 million compared to RON 16.457 million a year ago. Net income was RON 12.098 million compared to RON 11.626 million a year ago.

Latest news about S.C. Ropharma S.A.

S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-26	CI
S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-30	CI
S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-27	CI
S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-08	CI
S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-28	CI
S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2020	20-10-07	CI
S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2018	19-03-11	CI
Ropharma Plans To Acquire Seven Pharmacy Units	17-01-17	CI
ROPHARMA SA Reports Earnings Results for the Nine Months of 2016	16-11-14	CI
S.C. Ropharma S.A.’s Equity Buyback announced on January 14, 2015 has expired.	15-11-26	CI
Ropharma Announces Non-Consolidated Earnings Results for the Year 2014	15-05-14	CI
S.C. Ropharma S.A. announces an Equity Buyback for 50,959,936 shares, representing 10% of its issued share capital.	15-01-14	CI
S.C. Ropharma S.A. authorizes a Buyback Plan.	15-01-13	CI
Ropharma Reports Earnings Results for the First Half of 2014	14-08-18	CI
Ropharma Provides Earnings Guidance for the Full Year 2014	14-04-30	CI
Ropharma Reports Earnings Results for the Year 2013	14-02-18	CI
Ropharma Plans To Acquire Three Pharmacies	13-12-09	CI
Ropharma Reports Earnings Results for the Nine Months Ended September 30, 2013	13-11-11	CI
Ropharma Seeks Acquisitions	13-10-10	CI
Ropharma SA Brasov Reports Earnings Results for the First Half of 2013	13-08-13	CI
Ropharma Seeks Acquisitions	12-11-05	CI

Chart S.C. Ropharma S.A.

Duration

Period

More charts

Company Profile

Ropharma SA is a Romania-based company engaged in the pharmaceutical industry. The Company is active in the wholesale and retail of drugs. It also has a production facility of over-the-counter drugs and dietary supplements. The Company sells pharmaceutical products through its pharmacies located in the Romanian cities of Iasi, Vaslui, Suceava, Botosani, Bacau, Neamt, Vrancea, Mures, Harghita, Sibiu and Brasov. Through its distribution center, the Company provides drugs, food supplements, skin cosmetics and other products. It manufactures pharmaceutical products under the brand names Aesculap, Bioef and Eurofarmaco. As of December 31, 2011, Ropharma SA had six subsidiaries: Romanita-Farm Srl, Ropharma Production Srl, Aesculap Prod Srl, Ergo Farm Srl, Drops Farm Srl and Europharm Trading 7 SA.

Sector

Drug Retailers

More about the company

Income Statement Evolution

More financial data

Sector Retail - Drugs with Grocery

	1st Jan change	Capi.
S.C. ROPHARMA S.A.	-2.50%	21.39M
COSMOS PHARMACEUTICAL CORPORATION	-11.64%	3.62B
SUNDRUG CO.,LTD.	-0.09%	3.36B
TSURUHA HOLDINGS INC.	-23.44%	3.06B
LBX PHARMACY CHAIN	+7.46%	2.59B
KUSURI NO AOKI HOLDINGS CO., LTD.	-9.26%	1.75B
CREATE SD HOLDINGS CO., LTD.	+9.30%	1.35B
GREAT TREE PHARMACY CO., LTD.	-20.60%	957M
SHUYU CIVILIAN PHARMACY CORP., LTD.	-38.42%	704M
FARMACIAS BENAVIDES, S.A.B. DE C.V.	-0.53%	450M